Back to Journals » OncoTargets and Therapy » Volume 11

Early and late outcomes of bevacizumab plus chemotherapy versus chemotherapy alone as a neoadjuvant treatment in HER2-negative nonmetastatic breast cancer: a meta-analysis of randomized controlled trials

Total article views   HTML views PDF downloads Totals
7,998 Dovepress* 7,614+ 879 8,493
PubMed Central* 384 194 578
Totals 7,998 1,073 9,071
*Since 12 December 2018

View citations on PubMed and Google Scholar